Skip to main content

5 key steps to operationalize the Enhancing Oncology Model

5 key steps to operationalize the Enhancing Oncology Model

CMS’ new Enhancing Oncology Model seeks to improve cancer care coordination, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment.

Launched July 1, EOM replaces the Oncology Care Model as CMS seeks to build on lessons learned and challenges of cancer care cost management.

In this blog, we explore five best practices your oncology practice can use to kick-start EOM.

How to operationalize your Enhancing Oncology Model

1. Lay the foundation with core value-based care principles

While CMS models change, many value-based care elements are evergreen and can benefit from practices that:

  • identify physician champions;
  • inform and align practice leadership;
  • define success markers to track progress;
  • identify core team member roles and goals; and
  • establish quality measure reporting.

The latter may require EOM practices to add metrics to their electronic health records, such as depression screening and pain management. While this example is model-specific, reassessing quality programs and how EHRs can best support them is a core practice redesign principle. See step four below for more details.

2. Refine patient identification

Poorly defined VBC populations lead to missed opportunities for more targeted patient care and maximum performance incentives. This is particularly true for EOM, which CMS has limited to seven cancer types — breast cancer, small intestine/colorectal cancer, lung and prostate cancer and chronic leukemia, lymphoma and multiple myeloma — with select diagnostic codes and initiating chemotherapy treatments. Practices are required to abstract and submit clinical data elements not found in claims data for at least 90% of their total attributed episodes on a semi-annual basis.

CMS will use this information to apply clinical adjustments to control for known differences in episode expenditures. Ever-metastatic status will be an applicable adjustment for breast cancer, small intestine/colorectal cancer and lung cancer episodes. Human epidermal growth factor receptor 2 status will be an additional adjustment for breast cancer episodes.

Clinical specificity paints a living picture of a practice's oncology patients: who they are, what they need and how their experience and outcomes can be improved. This specificity is vital for oncology care episodes, which can include a broader range of services than more straightforward VBC models.

3. Earn and reinvest incentives

EOM practices may submit monthly enhanced oncology services claims for attributed patients in each month of the episode (up to six times total). Practices will receive $70 per EOM beneficiary per month and an additional $30 per EOM beneficiary per month for beneficiaries who are dually eligible for both Medicare and Medicaid.

The additional payment for dual eligible beneficiaries will not be included in the EOM practice’s total cost of care accountability. This is meant to avoid any potential disincentive for treating beneficiaries who tend to account for higher episode expenditures.

Month Enhanced Oncology Services payments are intended to support the implementation of enhanced oncology services. Providers can use these payments to fund ongoing redesign activities that foster practice-wide quality improvement beyond EOM model requirements.

4. Embrace practice redesign

Like VBC in general, practice redesign is a discipline. It takes time and requires continuous investment to pay dividends, financial and otherwise. Required EOM redesign elements include:

  • 24/7 access to clinicians who can access the patient’s EHR in real-time;
  • outpatient navigation services that span the cancer care journey;
  • detailed care plans shared with patients;
  • patient experience data; and
  • social drivers of health screening as part of routine practice.

The last requirement is new to EOM (versus OCM) and aligns with CMS' focus on health equity and how social determinants of health impact health outcomes.

Need key data insights backed by an analytics-first approach? Contact DataGen for a free consultation.

If you want more details on how EOM differs from CMS' prior demonstration (OCM), read DataGen’s September blog. To see DataGen's key findings and in-depth analysis of EOM’s national baseline and prediction module methodology, watch our recorded webinar.


Popular posts from this blog

BPCI Advanced – take advantage of the model extension now

The Bundled Payment for Care Improvement (BPCI) Advanced Model is now open for applications until May 31, 2023. This model provides a unique opportunity to acute care hospitals and physician group practices who are looking to: evaluate their bundle performance; rejoin if they have previously dropped out due to being under a convener; or take advantage of the changes to the model. With a small window to sign the participation agreement, you’ll need experts to process data quickly and accurately for evaluation. BPCI Advanced Program Details The Centers for Medicare & Medicaid Services (CMS) announced in October 2022 that this program will extend from January 2024 to December 2025. Data used for evaluation will be taken from the baseline period between October 2018 and September 2022. A participation agreement will be sent out in September 2023 and needs to be signed by October 2023 in order to participate. Those who apply before the May 31 deadline will benefit

BPCI Advanced Model Extension

CMS recently made several major announcements about the Bundled Payments for Care Improvement Advanced Model.  The model, which was due to expire at the end of 2023 (Model Year 6), will be extended for an additional two years through Dec. 31, 2025.  New applications will be accepted in 2023 for the two-year extension. Participants still active in Model Year 6 can continue without reapplying by signing an amended and restated participation agreement for Model Year 7.  New methodological changes will be implemented for Model Year 6, which starts on Jan. 1, 2023. Methodological changes include that: the CMS Discount Factor for medical clinical episodes will be reduced from 3% to 2%;  the Peer Group Trend Factor Adjustment cap for all clinical episodes will be reduced from 10% to 5%; the Major Joint Replacement of the Upper Extremity clinical episode category will become a multi-setting episode category by allowing episodes to be triggered when the procedure is performed in the hospital ou

You’ve been accepted to the Enhancing Oncology Model. Now what?

The Centers for Medicare and Medicaid Services Innovation Center recently announced approved applicants for the new Enhancing Oncology Model. If your facility has been selected by CMS, are you still weighing your options during the current baseline evaluation period?  Two deciding factors may include the program data that CMS provides and whether EOM is enough of an improvement over the prior Oncology Care Model to make your investment worthwhile. Another factor to consider: Will you have the resources in place to conduct a baseline evaluation before EOM’s program start on July 1, 2023? How EOM differs from OCM EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment. It includes three major updates: Fewer cancer types. Compared with OCM’s 21, EOM will be limited to seven common cancer types: breast, prostate, lung, small intestine/colorectal, multiple myeloma, lymphoma and chronic le